iMicrobes: Funding, Investors & Team (Sep 2026)
iMicrobes is a synthetic biology company on a mission to accelerate the transition to sustainable materials. We have developed a bio-manufacturing process that turns greenhouse gases (GHG) like methane into a wide range of net-zero chemicals, based on our patented microorganisms. We are a team of techno-optimists, backed by Y Combinator and are committed to fueling the circular economy through innovation and industrial partnerships. If you are a chemical company interested in reducing your carbon emissions, let’s talk! www.imicrobes.com
iMicrobes has raised $10.0M across 1 funding round on record, the most recent a Seed of $10.0M announced in Nov 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
iMicrobes Company Profile and Key Stats
Latest funding round on record: Nov 2024.
iMicrobes Funding Rounds
iMicrobes Founders and Leadership Team
Contact details for the iMicrobes team: 1 of 1 has an email address on file.
Start 14-day free trial →iMicrobes Funding Compared to Other Biotechnology Startups
iMicrobes' latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like iMicrobes in Biotechnology and Alameda
Companies Similar to iMicrobes
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
iMicrobes Funding FAQs
What does iMicrobes do?
iMicrobes is a synthetic biology company on a mission to accelerate the transition to sustainable materials. We have developed a bio-manufacturing process that turns greenhouse gases (GHG) like methane into a wide range of net-zero chemicals, based on our patented microorganisms. We are a team of techno-optimists, backed by Y Combinator and are committed to fueling the circular economy through innovation and industrial partnerships. If you are a chemical company interested in reducing your carbon emissions, let’s talk! www.imicrobes.com
How much funding has iMicrobes raised?
iMicrobes has raised $10.0M across 1 round on record. The most recent is a Seed of $10.0M announced in Nov 2024.
When did iMicrobes last raise funding?
iMicrobes' most recent funding round on record is a Seed of $10.0M, announced in Nov 2024.
Who founded iMicrobes?
FundedIQ lists Noah Helman (Founder) at iMicrobes.
Where is iMicrobes headquartered?
iMicrobes is based in Alameda, California, United States.
How many employees does iMicrobes have?
iMicrobes is in the 11-50 employee band.
How does iMicrobes' funding compare to other Biotechnology startups?
iMicrobes' latest round of $10.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's iMicrobes Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for iMicrobes is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.